Novartis AG Revenue 2010-2024 | NVS

Novartis AG revenue for the twelve months ending December 31, 2024 was $51.722B, a 10.85% increase year-over-year.

  • Novartis AG annual revenue for 2024 was $51.722B, a 10.85% increase from 2023.
  • Novartis AG annual revenue for 2023 was $46.66B, a 7.36% increase from 2022.
  • Novartis AG annual revenue for 2022 was $43.461B, a 17.81% decline from 2021.

Novartis AG Revenue 2010-2024 | NVS

  • Novartis AG annual revenue for 2024 was $51.722B, a 10.85% increase from 2023.
  • Novartis AG annual revenue for 2023 was $46.66B, a 7.36% increase from 2022.
  • Novartis AG annual revenue for 2022 was $43.461B, a 17.81% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B